FACSLyric Flow Cytometry System

Description: The National Cancer Institute intends to award a sole-source contract to Becton, Dickinson and Company for a FACSLyric Flow Cytometry System, including proprietary hardware, software, quality assurance materials, installation, training, warranty, and support. The procurement is based on FAR 6.302-1 because the system and its integrated proprietary components are available only from BD Biosciences. This is a presolicitation notice rather than a request for competitive proposals, and interested parties must submit capability statements by the stated deadline.